Isidre Ferrer Selected Research

Adenosine A2A Receptor (Adenosine A2A Receptors)

8/2019	Adenosine A2A-Cannabinoid CB1 Receptor Heteromers in the Hippocampus: Cannabidiol Blunts Δ9-Tetrahydrocannabinol-Induced Cognitive Impairment.
9/2014	Increased striatal adenosine A2A receptor levels is an early event in Parkinson's disease-related pathology and it is potentially regulated by miR-34b.
4/2014	Reduced striatal adenosine A2A receptor levels define a molecular subgroup in schizophrenia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Isidre Ferrer Research Topics

Disease

78	Alzheimer Disease (Alzheimer's Disease) 04/2024 - 10/2003
44	Neurodegenerative Diseases (Neurodegenerative Disease) 03/2024 - 05/2002
36	Parkinson Disease (Parkinson's Disease) 02/2024 - 05/2002
18	Adrenoleukodystrophy (Adrenoleukodystrophy, X-Linked) 01/2022 - 12/2004
16	Disease Progression 04/2024 - 12/2006
15	Prion Diseases (Transmissible Spongiform Encephalopathies) 06/2022 - 10/2008
14	Amyloid Plaque 01/2021 - 10/2003
14	Dementia (Dementias) 01/2021 - 09/2005
11	Cognitive Dysfunction 04/2024 - 02/2008
11	Sporadic Creutzfeldt-Jakob Disease 06/2022 - 01/2014
10	Schizophrenia (Dementia Praecox) 01/2020 - 07/2013
9	Creutzfeldt-Jakob Syndrome (Creutzfeldt-Jakob Disease) 12/2020 - 12/2004
9	Pick Disease of the Brain (Pick's Disease) 02/2016 - 03/2004
7	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 01/2024 - 04/2008
7	Tauopathies 01/2022 - 08/2005
7	Inflammation (Inflammations) 01/2022 - 03/2010
7	Frontotemporal Lobar Degeneration (Degeneration, Frontotemporal Lobar) 02/2016 - 12/2008
7	Huntington Disease (Huntington's Disease) 09/2013 - 11/2008
6	Neuroblastoma 11/2010 - 05/2002
6	Myofibrillar Myopathy 03/2009 - 06/2007
5	Neuroinflammatory Diseases 01/2020 - 01/2014
4	Neoplasms (Cancer) 01/2023 - 02/2003
4	Motor Neuron Disease (Primary Lateral Sclerosis) 01/2022 - 12/2008
4	Gliosis 01/2018 - 12/2008
4	Scrapie 01/2017 - 10/2008
4	Progressive Supranuclear Palsy (Steele Richardson Olszewski Syndrome) 02/2016 - 03/2010
4	Parkinsonian Disorders (Parkinsonism) 05/2011 - 05/2002
4	Synucleinopathies 03/2010 - 05/2006
3	Multiple Sclerosis 01/2022 - 12/2004
3	Seizures (Absence Seizure) 06/2020 - 02/2003
3	Lewy Body Disease (Lewy Body Dementia) 01/2018 - 09/2005
3	Demyelinating Diseases (Demyelinating Disease) 01/2017 - 12/2004
3	Mitochondrial Diseases (Mitochondrial Disease) 02/2014 - 12/2007
3	Bovine Spongiform Encephalopathy (Mad Cow Disease) 11/2009 - 10/2007
3	Muscular Diseases (Myopathy) 03/2009 - 06/2007
2	Starvation 01/2022 - 02/2014
2	Fatal Familial Insomnia 01/2021 - 01/2018
2	Infections 12/2020 - 02/2014
2	Acquired CJD 12/2020 - 08/2015
2	Frontotemporal Dementia (Semantic Dementia) 09/2020 - 06/2014
2	Lafora Disease 06/2020 - 01/2017
2	Psychotic Disorders (Schizoaffective Disorder) 11/2016 - 11/2014

Drug/Important Bio-Agent (IBA)

55	Proteins (Proteins, Gene)FDA Link 01/2024 - 05/2002
23	Amyloid (Amyloid Fibrils)IBA 01/2022 - 10/2003
20	LipidsIBA 01/2024 - 06/2005
18	Prion ProteinsIBA 04/2024 - 10/2008
15	Biomarkers (Surrogate Marker)IBA 04/2024 - 02/2014
14	Fatty Acids (Saturated Fatty Acids)IBA 01/2022 - 12/2004
10	Messenger RNA (mRNA)IBA 01/2020 - 07/2013
9	Protein AggregatesIBA 01/2017 - 10/2007
8	AntioxidantsIBA 01/2023 - 09/2008
8	alpha-SynucleinIBA 01/2019 - 05/2002
8	Phosphotransferases (Kinase)IBA 05/2018 - 03/2004
7	MicroRNAs (MicroRNA)IBA 04/2024 - 03/2009
7	PrionsIBA 06/2022 - 02/2014
7	EnzymesIBA 01/2022 - 03/2009
7	Peptides (Polypeptides)IBA 01/2021 - 01/2004
7	UbiquitinIBA 01/2018 - 10/2007
6	CytokinesIBA 01/2019 - 01/2014
5	SynucleinsIBA 09/2020 - 08/2010
5	RNA (Ribonucleic Acid)IBA 01/2020 - 07/2013
5	Docosahexaenoic AcidsIBA 01/2020 - 06/2005
5	Adenosine (Adenocard)FDA LinkGeneric 08/2019 - 03/2010
5	Protein Isoforms (Isoforms)IBA 05/2018 - 08/2005
4	CannabinoidsIBA 11/2018 - 05/2011
4	Phosphoric Monoester Hydrolases (Phosphatases)IBA 05/2018 - 04/2010
4	Presenilin-1IBA 02/2016 - 12/2006
4	Amyloid beta-PeptidesIBA 10/2009 - 01/2004
3	Dopamine (Intropin)FDA LinkGeneric 02/2024 - 08/2003
3	Member 1 Subfamily D ATP Binding Cassette TransporterIBA 01/2022 - 12/2012
3	Antipsychotic Agents (Antipsychotics)IBA 01/2020 - 11/2014
3	Adenosine A2A Receptor (Adenosine A2A Receptors)IBA 08/2019 - 04/2014
3	sarkosylIBA 04/2015 - 05/2006
3	Purinergic P1 Receptors (Adenosine Receptor)IBA 01/2015 - 10/2003
3	Levodopa (L Dopa)FDA LinkGeneric 04/2010 - 07/2002
2	Odorant Receptors (Odorant Receptor)IBA 03/2024 - 06/2013
2	ORALIT (ORS)IBA 03/2024 - 01/2015
2	Interleukin-6 (Interleukin 6)IBA 02/2024 - 01/2022
2	tau Proteins (tau Protein)IBA 02/2024 - 03/2010
2	Peptide Hydrolases (Proteases)FDA Link 06/2022 - 03/2010
2	EndocannabinoidsIBA 01/2022 - 01/2014
2	Cannabinoid Receptors (Cannabinoid Receptor)IBA 01/2022 - 01/2016
2	Codon (Codons)IBA 01/2021 - 11/2016
2	CannabidiolIBA 06/2020 - 08/2019
2	Amyloid Precursor Protein Secretases (beta-Secretase)IBA 01/2020 - 01/2010
2	CalciumIBA 01/2020 - 01/2017
2	ProteomeIBA 01/2020 - 01/2019
2	CB1 Cannabinoid Receptor (CB1 Receptor)IBA 08/2019 - 11/2018
2	NeuroserpinIBA 12/2017 - 02/2016
2	CalpainIBA 01/2017 - 01/2008
2	PresenilinsIBA 01/2017 - 02/2013
2	AlbuminsIBA 01/2017 - 07/2009
2	GlycogenIBA 11/2016 - 02/2014
2	Mitochondrial DNA (mtDNA)IBA 02/2016 - 02/2014
2	5-Methylcytosine (5 Methylcytosine)IBA 02/2016 - 06/2013
2	purineIBA 12/2015 - 01/2015
2	DNA (Deoxyribonucleic Acid)IBA 12/2015 - 08/2009
2	Sirolimus (Rapamycin)FDA Link 11/2015 - 09/2013

Therapy/Procedure

13	Therapeutics 04/2024 - 06/2008
2	Plasma Exchange 01/2017 - 07/2009